Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D017245:Foscarnet; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D003699:Hepatitis D / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000998:Antiviral Agents; D009943:Organophosphorus Compounds; D017245:Foscarnet; D010746:Phosphonoacetic Acid